Back to search

Canada· CA-DIN-00834319

ACETAZONE FORTE C8

A chlorzoxazon, kombinationen, exkl. psycholeptika product containing codeine phosphate + acetaminophen + chlorzoxazone, registered in Canada by TEVA CANADA LIMITED. The same ATC class is registered in 2 of our 19 countries.

ATC M03BB53

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedACETAZONE FORTE C8ATCM03BB53REGISTER NO.CA-DIN-00834319PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Chlorzoxazon, kombinationen, exkl. psycholeptika is registered in 2 of 19 countries.

Countries holding a registration under ATC M03BB53 (chlorzoxazon, kombinationen, exkl. psycholeptika), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 1 of them publish a price we can compare per daily dose

Chlorzoxazon, kombinationen, exkl. psycholeptika · ATC M03BB53

2 / 19 countries

  • Canada
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
CODEINE PHOSPHATE + ACETAMINOPHEN + CHLORZOXAZONE
Manufacturer
TEVA CANADA LIMITED
Country
Canada (CA)
ATC code
M03BB53
ATC class
Chlorzoxazon, Kombinationen, exkl. Psycholeptika
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under M03BB53

Chlorzoxazon, kombinationen, exkl. psycholeptika, as other registers publish it.

All chlorzoxazon, kombinationen, exkl. psycholeptika products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6c57a183-60c6-446f-9896-41a7d1b9a088
GET /v1/drugs/6c57a183-60c6-446f-9896-41a7d1b9a088?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "00834319",
  "form": "TABLET",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "M03BB53",
  "schedule": [
    "Narcotic (CDSA I)"
  ],
  "drug_code": "11339",
  "strengths": [
    "8 MG",
    "300 MG",
    "250 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "CODEINE PHOSPHATE",
    "ACETAMINOPHEN",
    "CHLORZOXAZONE"
  ],
  "product_categorization": null
}

See everything about chlorzoxazon, kombinationen, exkl. psycholeptika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.